News
NATURE | The CRISPR-baby scandal: what’s next for human gene-editing
Published: 27 February 2019
But others predict that the He affair might propel human gene editing forwards. Jonathan Kimmelman, a bioethicist specializing in human trials of gene therapies at in Montreal, Canada, argues that definitive action in the wake of the scandal could expedite global cooperation on the science and its oversight. “That would stimulate, not hinder, meaningful advance in this area,” he says.